A Comparison of the Efficacy and Safety of Mifepristone and Misoprostol Versus Misoprostol alone for Induction of Labour in Nigerian Women with Intrauterine Fetal Death: A Triple Blind Randomized Controlled Trial

Author:

Ekoh A1,Ebeigbe PN.1,Mofon C2

Affiliation:

1. Department of Obstetrics and Gynaecology, Delta State University Teaching Hospital, Oghara, Delta State, Nigeria

2. Department of Obstetrics and Gynaecology, Asaba Specialist Hospital, Asaba, Delta State, Nigeria

Abstract

ABSTRACT Background: Intrauterine foetal death (IUFD) is an unpleasant pregnancy outcome and prompt delivery of the dead foetus is usually desired by mothers. Unfortunately, spontaneous labour and delivery may not occur early and prolonged retention of the dead foetus in utero is life-threatening. Many of the agents currently used for the induction of labour may result in a prolonged delivery process. Objectives: To compare the efficacy and safety of mifepristone and misoprostol versus misoprostol alone for induction of labour in women with intrauterine foetal death. Materials and Methods: This was a triple-blind randomized controlled trial. Eighty women were randomized into two groups. The intervention group received a single oral dose of 200 mg mifepristone, followed by 6-hourly 50 μg misoprostol vaginal insertion, after 24-hour intervals. The control group received a placebo, followed by 6-hourly 50 μg misoprostol vaginal insertion, after 24-hour intervals. The primary outcome measure was the induction to delivery interval. Results: Maternal age, gestational age, parity and pre-induction bishop’s score were comparable between the two groups. The mean induction to the delivery interval in the intervention group was significantly less in the intervention group than the control group (18.78 ± 6.51 hours versus 37.10 ± 10.10; P < 0.001). The total dose of misoprostol required for induction of labour; the need for oxytocin augmentation of labour; and the observed side effects of misoprostol were all significantly less in intervention group than control group (P < 0.001; P < 0.01; and P = 0.03, respectively). Conclusion: The combination of mifepristone and misoprostol has greater efficacy and better safety profile than the use of misoprostol alone for induction of labour. This combination should be considered when induction of labour is indicated for IUFD.

Publisher

Medknow

Reference22 articles.

1. Comparative study of mifepristone and misoprostol versus misoprostol alone in induction of labour in late intrauterine fetal death;Hemalatha;Int J Reprod Contracept Obs Gynecol,2018

2. Role of combination of mifepristone and misoprostol verses misoprostol alone in induction of labour in late intrauterine fetal death:A prospective study;Panda;J Fam Reprod Heal,2013

3. A prospective comparative of mifepristone and misoprostol vs misoprostol alone for induction of labour in inntrauterine fetal death;Hoda;J South Asian Feder Obs Gynecol,2021

4. Effects mifepristone-misoprostol versus misoprostol in the management of intrauterine fetal death. A comparative study;Sindhuri;Arch Med Heal Sci,2020

5. Mifepristone plus misoprostol versus only-misoprostol in induction of labour in intrauterine fetal death;Praveena;Int J Pharm Biochem Res,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3